Predicting missing quality of life data that were later recovered : an empirical comparison of approaches by Fielding, Shona et al.
  
Predicting missing quality of life data that were later recovered: an 
empirical comparison of approaches 
 
Shona Fielding, Peter Fayers and Craig Ramsay 
 
DOI: 10.1177/1740774510374626 
Clin Trials 2010 7: 333 originally published online 24 June 2010 
The online version of this article can be found at: 
http://ctj.sagepub.com/content/7/4/333 
 
Introduction 
Missing data are a common problem in many areas of research. When a dataset 
includes a large proportion of missing data, subsequent analysis may be subject to 
bias unless dealt with appropriately. Possible approaches include complete case or 
available case analysis, joint or pattern mixture modelling and use of imputation [1]. 
Imputation is the substitution of an estimated value for one that is missing. There are 
two types of imputation – single value or multiple imputation.  
 
Outcomes from health-related quality of life (QoL) instruments are considered. 
Missing QoL outcomes are likely to be informative [2,3] . For example, patients with 
poorer QoL may have impaired physical functioning and may feel fatigued, therefore 
may be less likely to complete questionnaires. Conversely those who feel well might 
regard the questionnaires as no longer relevant, thereby not filling them in. There are 
two types of missing data: missing form (the focus here) when the whole 
questionnaire is missing, and missing item, when the form is returned with one or 
more items unanswered.  
 
There is extensive literature on the accuracy of different imputation strategies [4-12]. 
A number of case studies and simulation studies have shown multiple imputation (MI) 
  
to be superior to simple imputation in the presence of informative missing data [4-12]. 
However in these studies the missing data have been created artificially and the 
missing data patterns are predetermined or prespecified. It is not surprising that some 
imputation methods perform poorly for particular prespecified mechanisms. For 
example, simple methods such as mean imputation are only useful if the data are 
likely missing completely at random (MCAR). If not MCAR, this type of method is 
likely to produce biased results. Fielding et al. [2] showed that simple imputation was 
inadequate in the presence of missing not at random (MNAR) data and suggested MI 
might be more appropriate.    
 
The accuracy of different strategies of dealing with the missing data can never be 
truly assessed since the data are by definition ‘missing’. However, this paper takes an 
approach that compares imputation results against data subsequently recovered using 
a reminder system for questionnaires.  This allows the relative efficiency of different 
methods to be assessed. Use of imputation should always be regarded with 
circumspection, and we discuss the merits of the different approaches.  
 
Dealing with missing data 
Imputation 
Imputation involves replacing a missing value with a ‘best guess’. This could be 
based on previously observed scores (e.g. the last observation available for a 
particular person), expert opinion or previous studies. Additional data that may inform 
imputation are often contained within a dataset and can be utilised. The imputation 
process results in a complete dataset on which standard statistical analysis can be 
  
carried out. However, imputation cannot completely replace lost information and 
should be used with caution. Although a seemingly complete dataset is created, it is 
one that has been augmented in some sense and does not compensate for full 
information [13]. Imputed values will never be completely representative of the true 
value.  
Simple imputation 
 
In simple imputation a single value is substituted for one that is missing. Methods 
consist of those using data from all patients (cross-sectional) and those using 
information specific to the patient (longitudinal). Many cross-sectional methods exist 
[13] but those used here are:  simple mean imputation (mean score from observed data 
at a given assessment); minimum or maximum value of the observed data; and 
regression (using QoL and other variables in the dataset). For regression imputation 
the covariates associated with reminder response and the outcome can be identified 
using standard statistical tests such as independent t-tests and chi-squared tests as 
appropriate. A common but naïve longitudinal method is last observation carried 
forward (LOCF), where the last observed value is carried forward to replace a missing 
observation. This is sometimes referred to as last value carried forward. A similar 
method is baseline carried forward, where the baseline value is carried forward to 
each missing value.   
 
Each of these simple imputation methods provides a deterministic rule for imputing a 
single value for each that is missing. The advantage of simple imputation is that it is 
easy to carry out. However, a major disadvantage, especially for methods based on 
mean values or regression, is that variances of the variable undergoing imputation 
  
tend to become underestimated, leading to reduced standard errors which can impact 
on test statistics, p-values and confidence intervals [14]. 
Multiple imputation 
MI can overcome some of the problems associated with simple imputation. For each 
missing value, instead of a single deterministic estimate, a random value is selected 
from its distribution. This introduces uncertainty in the imputed values, and preserves 
the random variability (variance) of the variables. This process is repeated, generating 
multiple randomly different datasets.  Each dataset is analysed separately and the 
results combined using Rubin’s method [15]. Although a single random imputation 
may be reasonable if the proportion of missing data is small, without special 
corrective measures the inferences tend to overstate precision because the between-
imputation component of variability is omitted. Imputations may in principle be 
created under any kind of assumptions or model for the missing data mechanism and 
the resulting inferences will be valid under that mechanism.  Several approaches were 
used for randomly sampling from the distribution of the items with missing values 
and these are described. 
Approaches for monotone missingness 
A monotone missing data pattern occurs when no further observations are made on a 
patient following a number of completed assessments. For monotone missing data 
possible MI methods include: regression models, predictive mean match models or 
propensity scores. For the regression method a model is fitted to the continuous 
outcome with explanatory variables constructed from those covariates available 
within the dataset. Based on the fitted regression model, a new regression model is 
  
simulated from the posterior predictive distribution of the parameters and this is used 
to impute the missing values for each variable [16].  
 
The predictive mean match model also fits a regression model and obtains a set of 
predicted values. For each piece of missing data, a set of observed values for which 
the predicted values are closest to the predicted value of the missing observation are 
obtained. One of these observed values is randomly selected and imputed for the 
missing value. An advantage of this method over regression is that imputed values are 
always within the range of the data and thus ensures the imputed values are plausible.  
 
The third method for monotone missingness is the propensity score method. For a 
variable with missing values, a score is generated for each observation to estimate the 
probability that the observation is missing and this is called the propensity score. The 
observations are then grouped (usually five) according on these propensity scores. 
Within each group a set of observed scores are randomly selected with replacement to 
create a new set of observed scores. For each missing value an observation from this 
new set of observed scores is randomly selected and imputed. The disadvantage of 
this method is that information about correlations of repeated measures is lost. For all 
these methods formulation of the imputation model is an important step [17]. Failure 
to accommodate the model structure appropriately can cause bias in the resulting 
analysis [18]. Additional variables which are related to both missingness and outcome 
should also be included in the imputation model [1].  
Intermittent missingness 
Intermittent missing data occurs when one or more observations for a patient were 
missing before one was observed. For intermittent missing data, the Markov Chain 
  
Monte Carlo (MCMC) method can be used. The exact detail behind MCMC is 
provided elsewhere [15-16, 19]. MCMC can be used in two ways for intermittent 
missingness. The first approach applies MCMC on all the intermittent missing data 
and the second uses MCMC to make the data monotone and then employs one of the 
other more flexible monotone methods for the remainder of the data.  
Software for imputation 
Simple imputation does not require any specialist software and the routines can be 
programmed into any standard statistical software. MI is more complex, however, and 
some statistical software packages provide inbuilt procedures. The statistical software 
package STATA undertakes MI by chained equations using the ICE command [20]. 
The software package SAS uses the multiple imputation procedure (PROC MI) to 
carry out the imputation followed by PROC MIANALYZE to combine the results 
[19]. The package, SOLAS (Statistical Solutions Inc, Sargus, MA, USA) has been 
developed to handle missing data and perform MI. The work presented here used SAS 
and full technical details of these imputation procedures can be found in the SAS 
User’s Guide [19]. 
 
Repeated measures model 
QoL data collected in trials is often analysed using an analysis of covariance 
(ANCOVA) on the final endpoint.  Since longitudinal data has been collected an 
alternative is the repeated measures model [1,21]. This type of model assumes the 
data are MAR. It has several advantages over the simpler ANCOVA.  It takes into 
account correlations between the repeated measures and allows for missing data [21].  
  
The models are fitted using restricted maximum likelihood estimation, using for 
example the MIXED procedure in SAS [19].  
 
Pattern mixture model 
Pattern mixture models allow for different response models for each pattern of 
missing values [1,22]. The data are then a mixture of these weighted by the 
probability of each missing value or dropout pattern. To apply a pattern mixture 
model, the proportion of subjects for each pattern of missing data needs to be known. 
However, there can be a large number of potential patterns of missing data, causing 
difficulties in estimating all the model parameters in each pattern. Furthermore, for 
some patterns the model can be under identified, and not all the parameters can be 
estimated without additional assumptions or restrictions placed on the model [22]. 
Three possible restrictions for monotone missingness have been proposed: complete 
case missing value (CCMV); available case missing value (ACMV); neighbouring 
case missing value (NCMV) [1,15,22]. 
 
In summary under the CCMV restriction, the data from subjects in pattern one 
(complete cases) are used to impute the means for the missing observations in the 
remaining patterns. It is important to note that this restriction is only feasible when the 
number of cases in pattern one is sufficient to estimate these parameters reliably.  In 
the ACMV restriction, available data from subjects in all patterns are used to impute 
the means for the missing observations in the remaining patterns. This is less 
restrictive than CCMV restriction as more observations are used to estimate some 
parameters. Finally, for the NCMV restriction available data from subjects in the 
neighbouring pattern are used to impute the means for the missing observations in the 
  
remaining patterns. These three sets of restrictions result in a number of equations that 
need to be solved to obtain the unknown means and variance parameters. However, 
deriving the appropriate variance of the pooled estimates is complex. Curran [23] 
suggests an analytic technique using MI to avoid this problem and this has been 
implemented here.  
 
Datasets 
The datasets involved in this empirical work come from the Centre for Healthcare 
Randomised Trials in Aberdeen and include the physical and mental summary 
components of the SF36 [24] and the EuroQoL EQ5D score [25]. Data were collected 
at baseline (at a clinic appointment) with subsequent follow-up through postal 
questionnaires. To reduce the number of unreturned follow-up questionnaires, one or 
more reminders were issued to those who did not respond within a specified time 
(usually two weeks). This recovered a substantial portion of otherwise missing data.  
 
Five randomised trials are presented. Several quality of life instruments were 
administered in the trials, but only the EQ5D results are presented in detail. 
1. REFLUX (N=357) evaluated the clinical effectiveness and cost-effectiveness of 
early laparoscopic surgery compared with continued medical management 
amongst people with gastro-oesophageal reflux disease. QoL data (EQ5D, SF12 
and gastro-oesophageal reflux symptoms) were collected at baseline, three months 
and twelve months after surgery (or equivalent for those managed medically). 
Trial analysis consisted of ANCOVA of the 12 month treatment difference 
(surgical versus medical management) adjusting for baseline QoL and a number 
of other baseline characteristics (age, sex and body mass index (BMI)) [26]. 
  
2. MAVIS (N=910) was a randomised controlled trial of multi-vitamin and mineral 
supplementation in persons aged 65 and over to reduce infection rates and 
antibiotic usage. QoL data (EQ5D and SF12) were collected at baseline, six and 
twelve months follow-up. ANCOVA was used to estimate the mean difference at 
12 months between groups (placebo versus supplementation) after adjusting for 
baseline QoL values and the baseline covariates - age group, sex and type of 
housing [27].  
3. RECORD (N=5292) was a placebo-controlled trial of daily oral vitamin D and 
calcium supplementation in the secondary prevention of osteoporosis related 
fractures in older people. QoL was assessed at 4, 12, 24, 36 and 48 months using 
the EQ5D and the SF12 instruments. An ANCOVA adjusting for baseline QoL, 
age group, gender, time since recruiting fracture and type of fracture was carried 
out to assess treatment effects on QoL at 24 months. The calcium supplementation 
(or no supplementation) treatment comparison will be used for illustration [28]. 
4. KAT aimed to measure the long-term clinical and cost effectiveness of different 
types of knee replacement. There were 1517 patients randomised between patella 
resurfacing or not. Functional status (Oxford Knee Score) and quality of life 
(SF12 and EQ5D) were measured at baseline, three months and annually after 
their operation. An ANCOVA for the two-year treatment comparison adjusting for 
baseline QoL, age group, sex and extent of arthritis was carried out [29]. 
5. PRISM (N=1324) evaluated the clinical effectiveness and cost-effectiveness of 
symptomatic versus intensive bisphosphonate therapy for the management of 
Paget’s disease. QoL was assessed through yearly postal questionnaires including 
the EQ5D, SF36 and disease-specific QoL as measured by the Arthritis Specific 
Health Index. The primary endpoint in the PRISM trial was treatment effect at two 
  
years adjusting for baseline QoL, and a number of Paget’s disease-related 
variables [30]. 
 
The missingness mechanism in our studies was found to be a mixture of MCAR, 
missing at random (MAR) and possible MNAR [3]. Knowing this mechanism is 
important in determining which of the methods considered here are likely to provide 
the least biased results.   
 
Methods 
In this paper we use an empirical approach to compare the different strategies for 
dealing with missing data. The approach outlined in this paper differs from previous 
literature in that it is based on real data from trials in which initially missing data was 
later recovered using a reminder system. This paper deals with missing forms, so 
imputation is carried out on complete QoL dimensions rather than individual items 
comprising the dimension. It is only the data from the questionnaires that were 
obtained by reminder that are imputed and the not the data from the questionnaires 
that were never obtained. The data collected by reminder are initially regarded as 
missing, as if no reminder system had been used. This portion of data is then imputed 
and results from analyses of the trial compared to what was actually obtained when 
using all responders (including the reminder data). The impact of the imputation 
method on estimation of treatment difference is evaluated and the different strategies 
compared. 
 
For each trial dataset, the relevant covariates for imputation were identified using 
standard statistical procedures (e.g. t-tests and chi-squared tests) to identify those that 
  
were significantly associated with both the outcome (QoL) and the indicator of 
reminder response.  Two imputation models were then used. Firstly a model including 
only covariates (involved in the original trial analysis plus any additional variables 
related to missingness and outcome) and secondly the same covariates plus previous 
QoL.  
 
A repeated measures model was carried out for each trial. The baseline assessment 
was used as a covariate rather than incorporated into the repeated measures. The 
model also adjusted for the same covariates that were used in the original trial 
ANCOVA.  This allowed the treatment difference estimates to be more comparable to 
the original analysis carried out by the trial researchers. 
Determining the best method 
For each dataset, the calculated treatment difference and its corresponding 95% 
confidence interval were obtained for the observed data, data under simple 
imputation, under MI, from the repeated measure model and from the pattern mixture 
models. The absolute bias in the calculated treatment effect was calculated. The full 
range of results is provided for the EQ5D QoL score and brief details given for the 
SF12 summary scores.  
Secondly the precision of the estimate is important when determining accuracy of the 
different methods. The width of the confidence interval for the observed result and 
that under the imputation/modelling strategies was obtained. The ratio of this width 
was calculated. Ideally the ratio would be equal to one such that the observed 
precision was also seen in the imputation. The ‘best’ method was identified as the 
method which showed the smallest bias, but also took into account the precision. In an 
  
ideal world a ‘perfect imputation’ would result in an estimate with no bias and 
variance equal to variance in the observed data and it is against this standard that the 
ratio of CI width was assessed.  
 
Results 
Table 1 shows the percentage of each type of responder from the total sample size 
(immediate, reminder or non-responder) at each assessment for each trial. It is seen 
that MAVIS had an excellent response rate to the initial mailing, while in REFLUX a 
large amount of data were recovered through the reminder responses. 
 
In each trial analysis an ANCOVA model for treatment difference in QoL scores at 
the final endpoint adjusting for other covariates was carried out. This final endpoint 
was at one year follow-up for REFLUX and MAVIS, but at two years for RECORD, 
KAT and PRISM. The proportion of missing responses (or reminder-response here 
that will be imputed) from the total number of responders at these final endpoints was: 
REFLUX – 57%; MAVIS – 12%; RECORD – 22%, KAT – 18%; PRISM – 18%. 
Table 2 shows the covariates for each trial that were identified as being significant in 
the models for simple regression imputation and those involved in the MI procedures. 
Table 3 shows the observed treatment difference (95% CI) in EQ5D scores. The 
‘absolute bias*100’ and ‘ratio of the CI width’ are presented in Table 3 for each of the 
imputation and modelling methods. The results under simple imputation, multiple 
imputation and the alternative procedures are discussed in turn. This is followed by a 
comparison between these different options for dealing with missing data. 
 
  
Simple imputation 
The choice of simple imputation method can have an impact on whether the 
calculated treatment difference is significant. For example in the REFLUX trial the 
methods of BCF, LOCF and regression all provide a significant treatment difference 
(p<0.05). In the REFLUX and MAVIS trials the baseline carried forward (BCF) 
method provided the smallest total bias of the simple imputation procedures 
considered. The precision based on the ratio of CI width was equal to one in MAVIS 
using BCF, but in REFLUX this ideal value occurred with LOCF. In RECORD and 
KAT, LOCF provided the least biased estimates of treatment difference (bias = 0.2 
and bias = 0. 4 respectively) and for RECORD the ratio of CI width was equal to one. 
Mean imputation and regression imputation tended to provide most bias. In the 
PRISM trial the maximum method showed least bias (bias = 0.4) compared to 1.0 for 
the BCF method. However, BCF was much better at maintaining precision as the ratio 
of CI width was one. 
 
There were 13 other QoL scores measured across the five trials in addition to EQ5D. 
LOCF was the most accurate (least biased) in five of these. BCF showed least bias on 
four occasions, mean value imputation for three QoL scores and finally maximum 
value imputation for one instrument. Combining these results with the EQ5D data 
shows that the longitudinal simple imputation methods (BCF and LOCF) provided the 
greatest number of ‘best’ (least biased) estimates (13 of 18 QoL scores).    
Multiple imputation 
As with simple imputation the choice of MI had an impact on the calculated estimates 
of treatment difference.  MCMC imputation was carried out on all the missing data as 
it allows for the intermittent missing data pattern. For the regression, predictive mean 
  
match and propensity score methods, MCMC was first used to make the data 
monotone.  The predictive mean match model was the least biased method for four of 
the five trials (REFLUX, MAVIS, RECORD and PRISM). MCMC for intermittent 
missingness showed an equivalently small bias as the predictive mean match for the 
RECORD trial. In KAT, the regression model (including previous QoL scores) 
resulted in least bias. The ratio of CI width was reasonable (equal to or close to one) 
for the predictive man match model in each of the trials.   
 
MI for the other 13 QoL scores within the trials showed that MCMC for intermittent 
missingness was least biased for four of them, as was the predictive mean match 
model. A propensity model was least biased on three occasions and finally regression 
was the least biased MI method for only two of the twelve QoL scores. 
Other strategies 
Pattern mixture models (incorporating MI) did not perform that well for REFLUX or 
KAT data in terms of bias. In the MAVIS trial under CCMV the calculated treatment 
estimate showed a much greater bias than the other two restrictions and the ratio of CI 
width was much larger than one. Across all trials, of the three restrictions it was either 
ACMV or NCMV which performed best with NCMV tending to provide the better 
precision. The estimates obtained using a repeated measures model were more 
accurate than pattern mixture modelling for the REFLUX, MAVIS, RECORD and 
KAT trials. Pattern mixture models appeared to perform better for PRISM in terms of 
bias, although the precision was reasonable in both cases. However one note of 
caution is that the results for the pattern mixture models are based on only those 
patients with a monotone missingness pattern.   
  
Comparison between the different approaches for dealing with missing data 
The paragraphs above have discussed in turn the results of the simple imputation, MI, 
repeated measures model and pattern mixture models. Table 3 shows the calculated 
bias (bias*100) for each of these strategies for the EQ5D score in the five different 
trials. In four of the five trials, one of the MI strategies showed the least bias. In the 
fifth a pattern mixture model on the monotone missing data (using NCMV, bias = 0.1) 
was least biased but this was closely followed by two of the MI procedures (bias = 
0.2) carried out on all the missing data. The most accurate MI strategy was the 
predictive mean match model.  On the whole it was one of the MI strategies which 
provided the best precision – that is, the ratio of the CI width was either equal or close 
to one. In these five trials MI consistently provided results with low bias and best 
precision. 
Discussion 
It has been shown in this paper that different imputation strategies can impact on the 
eventual calculated treatment estimates to varying degrees. Generally the longitudinal 
methods (BCF and LOCF) were the ‘best’ simple imputation methods. MCMC 
imputation to make the data monotone followed by a predictive mean match model 
was good and the best MI method for the EQ5D scores in four of the trials. Usually 
one of the MI procedures provided least biased results and the most precise. This was 
true for the data presented and for the other QoL measures used within the five trials. 
The ratio of CI width was close to one and the standard errors tended to reflect those 
calculated in the observed dataset. This is important when calculating the confidence 
intervals and p-values for significance [14]. The MI strategies seemed preferable to 
the other procedures considered. 
 
  
The REFLUX trial contained the most missing data (and correspondingly, the greatest 
amount of data collected via reminder-response). MCMC to make the data monotone 
followed by a predictive mean match model was clearly more superior over the 
simple imputation methods. Pattern mixture models for this dataset performed 
particularly badly when compared to the standard MI models or the repeated measures 
model. The difference between simple and MI is less obvious as the amount of data 
being imputed is reduced. For example, in the MAVIS trial only 12% of data is 
undergoing imputation and in this trial one of each of the simple and MI methods 
were equivalent in providing the smallest bias.  
 
Previous work has shown evidence against MCAR for the five datasets [3]. Therefore, 
it would be unlikely that simple imputation would be appropriate, whereas MI might 
be more suitable. The simple imputation methods assume that data are MCAR –
unrelated to anything observed. MI methods assume MAR and that missing data are 
related to observed data (covariates and/or outcome) [1]. If there is no evidence for 
MCAR then simple imputation methods should be used with caution or not at all.  It is 
likely that QoL data is frequently missing for a reason related to changing QoL and so 
MI should be preferable because MAR is more plausible. The CCMV restriction for 
the pattern mixture model assumes MCAR and therefore not surprisingly this 
performs worst of the three restrictions. ACMV and NCMV are based on the MAR 
assumption which as we have already discussed is more plausible in this context.  The 
pattern mixture models were carried out on a reduced dataset which only contained 
those patients with a monotone missing data pattern. This may account for the 
differences seen between ACMV/NCMV and the MI models. 
  
Molenberghs and Kenward [14] discuss the merits of the different MI approaches. 
They promote the use of a regression or predictive mean match model for the 
longitudinal setting. An advantage of a predictive mean match model over regression 
is that imputed values are always within the range of the data [1]. In situations of 
monotone missingness, it is expected that the MCMC approach and the regression 
method should lead to similar answers. Any difference is due largely to the different 
prior distribution used [14]. Regression and predictive mean match imputation have 
been shown to be the most accurate in this current situation, with the propensity score 
model on the whole performing poorly in comparison. A reason for this is given by 
Molenberghs and Kenward [14] (page 144): 
 “The propensity score method uses only the covariate information 
associated with whether the imputed values are missing. It does not use 
associations among variables; As a consequence, while it can be effective 
for inferences about the distributions of individual imputed variables, it is 
not appropriate for analyses involving relationships among variables.” 
[14]  
 
If the model used for analysis and the imputation model are the same, the 
resulting estimates under imputation will be equivalent to those obtained by 
maximum likelihood, for example using a repeated measure design [17]. 
However, when the imputation model uses covariate information which is 
potentially related to the missing QoL values, the estimates may be different.  
 
There is increasing evidence from simulation studies that MI provides more 
robust treatment estimates and appropriate standard errors [4-12]. Each of these 
  
authors has compared MI to a simpler alternative or complete case strategy. In 
some situations MI was shown to perform at least as well in terms of treatment 
effects but on the whole provided a more realistic standard error. Our study 
complements these studies using real data with reminders rather than simulated 
missing data.  
 
One note of caution of the use of imputation is with regard to its validity when 
there is a large proportion of missing data. For example, the proportion of data 
obtained through reminders for REFLUX was 57% and to impute this much 
data should be done so with caution. Imputation is often regarded as a tool to 
assess sensitivity of results to missing data rather than a primary analysis 
[1,4,31]. The methods presented here could be used to identify which methods 
would be most appropriate.  One limitation of the current work is that we have 
not considered the impact of the different strategies on the eventual trial result. 
This is an important consideration and is addressed in a future paper. 
 
A second limitation was the use of the criteria of the ratio of CI width being 
equal to one as a proxy for precision of the imputation procedure. A perfect 
imputation procedure would result in the variance of the imputed estimate being 
equal to the variance of the full data estimate and the ratio equal to one.  
However, in practice it might be that the value of one was obtained due to a bias 
in the imputed estimate and thus it is possible that a value of one does not 
suggest an optimal imputation. In situations where there is a large amount of 
missing data, the variance is likely to be underestimated and the criteria of the 
ratio of CI width has less standing. However, since it is unlikely imputation 
  
would be used in these situations anyway, despite the concern, we felt that using 
this ratio of CI width as a measure of precision was a fair assumption to make. 
 
 
The rationale underlying our approach is that the ‘reminder-responders’ are 
likely to be representative of those who do not respond at all.  Thus we were 
able to identify possible suitable imputation methods or an appropriate 
modelling alternative. This method could then be used on the actual missing 
data to allow more patients (and data) to be included in the final analysis.  
Although it can never be proved that they are representative, it was found that 
the mechanism behind reminder-response was usually the same as the 
mechanism behind non-response for each of these trials [3].  This suggests that 
the rationale behind the approach presented in this paper is valid. However since 
the data required to prove this are missing, the strategies outlined should be 
used as a sensitivity to results rather than a primary analysis [17]. 
Conclusion 
As Huson et al. [7] observe there is no one imputation technique that is applicable for 
all possible missing data patterns and missing data mechanisms. However, here we 
have shown that MI was more suitable then both simple imputation methods and 
repeated measures models when missing data was found to be informative. MI models 
the uncertainty in the missing data and is based on the MAR assumption, which is 
more plausible in the QoL setting. When deciding on the best model for imputation it 
is recommended that all the variables in the analysis model are included plus any 
additional variables which are related to both outcome and missingness. MI is the 
hard way to analyze data where missingness is MAR and will only provide a benefit 
  
when the analyst has additional information that is related to QoL both when the 
response is observed and when it is missing [1]. We suggest that where possible 
reminder data should always be collected and can be used to identify suitable 
imputation procedures. This ‘best’ choice can then be used on the actual missing data 
to allow more patients to be included in analysis.  
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Tables 
Table 1: Percentage of each type of responder in each trial 
 
  Type of responder (%) 
Trial Assessment Immediate Reminder Non-responder 
REFLUX (N=357) 3 months 39 47 14 
 12 months 38 51 11 
MAVIS (N=910) 6 months 91 4 5 
 12 months 81 11 8 
RECORD (N=5292) 4 months 58 20 22 
 12 months 54 17 29 
 24 months 51 14 35 
KAT (N=2356) 3 months 79 9 12 
 1 year 74 13 13 
 2 years 69 15 16 
PRISM (N=1324) 1 year 85 6 9 
  2 years 63 14 23 
 
  
Table 2: Covariates involved in the imputation models  
Trial 
Covariates involved in simple imputation 
regression  
Covariates involved in multiple imputation 
models 
REFLUX Gender, age group, BMI group, treatment, baseline QoL 
Treatment baseline QoL sex, age, BMI 
MAVIS Gender, residence type, age group, baseline QoL 
Age group, gender, residence type, treatment, 
presence of chronic infection 
RECORD Gender, time since recruiting fracture, fracture type, age group, 4m QoL 
Treatment, gender, age group, time since 
recruiting fracture, type of fracture (proximal or 
distal or vertebral), age group, residence type 
after fracture 
KAT Gender, age, ASA grade 
Age group, treatment, extent of knee arthritis, 
any hospital readmissions, further knee 
admissions 
PRISM Baseline QoL, Treatment, a number of Paget related variables 
Treatment, age and a number of Paget's 
related variables 
 
 
 
 
  
Table 3: Accuracy results of estimates using different approaches – Bias*100 (Ratio of CI width) 
 REFLUX MAVIS RECORD KAT PRISM 
% of responses from reminder 57% 12% 22% 18% 18% 
Observed treatment difference 
(Units*100) 4.7 -1.9 1.5 1.3 1.5 
Observed 95% CI (units*100)  (-0.3,10)  (-4,0.2)  (0,30)  (-1.0,4.0)  (-2.0,5.0) 
Simple imputation methods  Bias*100 (Ratio of CI width) 
Mean 3.1  (0.7) 0.6  (1.0) 0.5  (0.8) 0.9  (1.2) 1.2  (1.3) 
Maximum 1.9  (0.8) 1.2  (1.2) 1.0  (1.0) 1.4  (1.2) 0.4  (0.9) 
Baseline carried forward 1.4  (0.6) † 0.2  (1.0) 0.4  (0.7) 0.8  (1.0) 1.0  (1.0) 
Last observation carried forward 2.1  (1.0) † 0.8  (1.0) 0.2  (1.0) 0.4  (1.2) 0.9  (0.9) 
Regression  1.8  (0.5) † 0.4  (0.8) 0.4  (0.9) 0.8  (1.0) 1.1  (0.4) 
Multiple imputation methods           
MCMC for intermittent 4.5  (1.4) † 0.7  (1.2) 0.2  (1.1) 0.2  (1.2) 0.9  (1.0) 
Regression model* 1.3  (1.6) 0.7  (1.4) 0.3  (1.2) 0.8  (1.0) 1.0  (1.0) 
Predictive mean match model* 0.8  (1.1) 0.1  (1.0) 0.2  (1.2) 0.9  (1.0) 0.3  (1.3) 
Propensity model*  1.6  (1.0) 0.4  (1.2) 0.4  (1.4) 0.6  (1.6) 1.1  (1.0) 
Regression model** 2.6  (1.7) 0.6  (1.2) 0.4  (0.9) † 0.1  (1.2) 1.3  (1.0) 
Predictive mean match model** 2.7  (1.7) 0.2  (1.0) 0.3  (1.3) † 0.3  (1.2) 0.6  (0.9) 
Propensity model**  1.1  (1.4) 0.4  (1.2) 0.3  (1.3) † 0.9  (1.0) 0.9  (1.0) 
Modelling strategies           
Repeated measures model# 3.3  (1.2) † 0.4  (1.2) 0.1  (1.1) 0.4  (1.2) 0.9  (1.0) 
Pattern mixture (CCMV) 8.3  (1.4) † 19.9  (18.6) 0.4  (1.2) 1.8  (1.4) 0.6  (1.1) 
Pattern mixture (ACMV) 8.3  (1.3) † 0.6  (1.2) 0.3  (1.2) 1.9  (1.4) 0.7  (1.0) 
Pattern mixture (NCMV) 9.3  (1.2) † 0.6  (1.2) 0.1 (1.1) 1.9  (1.4) 0.6  (1.1) 
* MI model based on the ANCOVA model and additional covariates; ** MI model based on the 
ANCOVA model, additional covariates and previous QoL; 
# adjusted for covariates in original ANCOVA model; † p<0.05;  
MCMC - Monte Carlo Markov Chain; CCMV- complete case missing value restriction; 
ACMV - available case missing value restriction; NCMV - neighbouring case missing value 
Bias  = |observed treatment difference – treatment difference under imputation| 
Ratio of CI width = width of 95% CI for treatment difference under imputation (or modelling) / width 
of 95% CI for observed treatment difference 
 
 
